BRPI0515040A - testosterone gels comprising propylene glycol as a penetration enhancer - Google Patents
testosterone gels comprising propylene glycol as a penetration enhancerInfo
- Publication number
- BRPI0515040A BRPI0515040A BRPI0515040-0A BRPI0515040A BRPI0515040A BR PI0515040 A BRPI0515040 A BR PI0515040A BR PI0515040 A BRPI0515040 A BR PI0515040A BR PI0515040 A BRPI0515040 A BR PI0515040A
- Authority
- BR
- Brazil
- Prior art keywords
- propylene glycol
- penetration enhancer
- testosterone gels
- testosterone
- gels
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
GéIS DE TESTOSTERONA COMPREENDENDO PROPILENO GLICOL COMO FACILITADOR DE PENETRAçãO. A presente invenção refere-se a géis composições farmacêuticas contendo testosterona, e a métodos que utilizam os mesmos.TESTOSTERONE GELS UNDERSTANDING PROPYLENE GLYCOL AS A PENETRATION FACILITATOR. The present invention relates to gels, testosterone-containing pharmaceutical compositions, and methods using them.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04292170.0 | 2004-09-09 | ||
EP04292170A EP1634583A1 (en) | 2004-09-09 | 2004-09-09 | Testosterone gels comprising propylene glycol as penetration enhancer |
US63836004P | 2004-12-23 | 2004-12-23 | |
US60/638,360 | 2004-12-23 | ||
PCT/EP2005/010293 WO2006027278A1 (en) | 2004-09-09 | 2005-09-07 | Testosterone gels comprising propylene glycol as penetration enhancer |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0515040A true BRPI0515040A (en) | 2008-07-01 |
BRPI0515040B1 BRPI0515040B1 (en) | 2021-10-13 |
Family
ID=39381985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0515040-0A BRPI0515040B1 (en) | 2004-09-09 | 2005-09-07 | TESTOSTERONE GELS INCLUDING PROPYLENE GLYCOL AS A PENETRATION Enhancer |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2008512425A (en) |
BR (1) | BRPI0515040B1 (en) |
EA (1) | EA013430B1 (en) |
HK (1) | HK1099887A1 (en) |
IL (1) | IL181583A0 (en) |
MX (1) | MX2007002814A (en) |
NZ (1) | NZ553446A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2147674A1 (en) * | 2008-07-24 | 2010-01-27 | Besins Healthcare | Transdermal pharmaceutical compositions comprising danazol |
CN107949389A (en) * | 2015-09-30 | 2018-04-20 | 富士胶片株式会社 | Percutaneous absorbtion composition |
TW201922260A (en) * | 2017-10-30 | 2019-06-16 | 日商帝國製藥股份有限公司 | Formulation for transdermal administration |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0399432B1 (en) * | 1989-05-25 | 1994-06-22 | Takeda Chemical Industries, Ltd. | Transdermal therapeutic composition |
US5968919A (en) * | 1997-10-16 | 1999-10-19 | Macrochem Corporation | Hormone replacement therapy drug formulations for topical application to the skin |
ES2283446T3 (en) * | 2000-12-22 | 2007-11-01 | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL | COMPOSITION OF GEL BASED ON ALCOHOL FOR THE TREATMENT OF HYPOGONADISM BY TRANSESCROTAL ADMINISTRATION. |
EP1317921B1 (en) * | 2001-12-07 | 2009-08-19 | Besins International Belgique | Gel or solution containing dihydrotestosterone, its manufacture and use |
MY139721A (en) * | 2002-04-19 | 2009-10-30 | Cpex Pharmaceuticals Inc | Pharmaceutical composition |
-
2005
- 2005-09-07 BR BRPI0515040-0A patent/BRPI0515040B1/en active IP Right Grant
- 2005-09-07 JP JP2007530680A patent/JP2008512425A/en active Pending
- 2005-09-07 NZ NZ553446A patent/NZ553446A/en unknown
- 2005-09-07 EA EA200700580A patent/EA013430B1/en unknown
- 2005-09-07 MX MX2007002814A patent/MX2007002814A/en active IP Right Grant
-
2007
- 2007-02-27 IL IL181583A patent/IL181583A0/en unknown
- 2007-05-28 HK HK07105601.3A patent/HK1099887A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ553446A (en) | 2010-05-28 |
IL181583A0 (en) | 2007-07-04 |
EA013430B1 (en) | 2010-04-30 |
JP2008512425A (en) | 2008-04-24 |
EA200700580A1 (en) | 2007-08-31 |
HK1099887A1 (en) | 2007-08-24 |
MX2007002814A (en) | 2007-05-16 |
BRPI0515040B1 (en) | 2021-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA87158C2 (en) | Testosterone gels CONTAINING propylene glycol as penetration enhancer | |
BRPI0914682B8 (en) | heteroaryl compounds and compositions comprising said compounds | |
CR11427A (en) | 2-FLUORO-2 - DEOXITETRAHYDROURIDINS AS INHIBITORS OF CITIDINE DESAMINASE | |
UY29112A1 (en) | DERIVATIVES OF CONDENSED PIRAZOL, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION | |
CL2008002319A1 (en) | Compounds derived from pyrrolopyrimidine; pharmaceutical composition comprising said compounds; and its use to treat cancer. | |
CL2007000311A1 (en) | Compounds derived from chromen-2-one; pharmaceutical composition that includes them; and their use in the treatment of a proliferative disorder such as cancer. | |
BR112016015105A2 (en) | VAR2CSA-DRUG CONJUGATES | |
EA201300242A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED ACYLANILIDES | |
EA200702550A1 (en) | METHOD OF OBTAINING EPOXIDE | |
CR9253A (en) | HER ANTIBODY DOSAGE SETTING | |
ECSP088633A (en) | MODIFIED LISINE MIMETIC COMPOUNDS | |
CR9949A (en) | 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITORS (FLAP) | |
BRPI0617294B8 (en) | pharmaceutical composition in hydroalcoholic gel and use of testosterone | |
CR9786A (en) | BENCIMIDAZOL-THIOPHEN COMPOUNDS | |
ECSP11011054A (en) | THERAPEUTIC ANTIVIRAL PEPTIDES | |
AR054937A1 (en) | BIODEGRADABLE GUM | |
BR122018009866B8 (en) | methods for preparing aminocyclohexyl ether compounds and intermediate compounds | |
ATE510822T1 (en) | POTASSIUM CHANNEL INHIBITORS | |
ECSP088745A (en) | SUBSTITUTED DERIVATIVES OF CHROMANOL AND ITS USE | |
UY28917A1 (en) | DERIVATIVES OF TETRAHYDROISOQUINOLILSULFONAMIDS PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USE | |
CR20120544A (en) | FUNGICIDE BLENDS I UNDERSTANDING QUINAZOLINAS | |
GT200600121A (en) | NEWS DERIVED FROM TRIAZOLOPIRIMIDINE | |
CL2011001122A1 (en) | Compounds derived from alkylheterocycles carbamates; preparation procedure; pharmaceutical composition; and its use to prevent or treat acute or chronic pain, neurological and psychiatric pathologies, cardiovascular diseases, among others. | |
BRPI0913401A2 (en) | c-substituted pregn-4 and en-21,17-carbolactones and pharmaceutical preparations containing them | |
BRPI0515040A (en) | testosterone gels comprising propylene glycol as a penetration enhancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: BESINS HEALTHCARE LUXEMBOURG SARL (LU) |
|
B25G | Requested change of headquarter approved |
Owner name: BESINS HEALTHCARE LUXEMBOURG SARL (LU) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/09/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |